Comparison of survival outcomes between ameloblastic carcinoma and metastasizing ameloblastoma: A systematic review.

ABSTRACT:

Purpose

To investigate and compare the demographic data, occurrence of recurrence and metastasis, and survival prognosis between ameloblastic carcinoma (AC) and metastasizing ameloblastoma (MA), based on appropriate and currently accepted eligible diagnostic criteria, in a systematic review of the literature.

Methods

An electronic search was undertaken, last updated in December 2021. Eligibility criteria included publications having enough clinicopathological information to confirm the diagnosis of these tumors.

Results

Seventy-seven publications reporting 85 ACs and 43 MAs were included. Both tumors were more frequent in mandible and showed different clinical profiles regarding patients' sex and age. There was no difference in the estimated cumulative survival betwee

SUBMITTER: Chrcanovic BR 

PROVIDER: S-EPMC9544829 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature